메뉴 건너뛰기




Volumn 66, Issue 2, 2004, Pages 188-192

Formulation and evaluation of propranolol hydrochloride oral controlled release matrix tablets

Author keywords

[No Author keywords available]

Indexed keywords


EID: 34547614947     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (23)

References (12)
  • 2
  • 3
    • 77949311846 scopus 로고    scopus 로고
    • US Patent No, US 5 783 212
    • Fassihi, R. and Yang. L., US Patent No., US 5 783 212, 1998.
    • (1998)
    • Fassihi, R.1    Yang, L.2
  • 5
    • 77949315408 scopus 로고    scopus 로고
    • Benowitz, N.L., In; Katzung, B.G., Basic and Clinical Pharmacology, 6th Edn., Prentice-Hall International Inc., New York, 1995, 157.
    • Benowitz, N.L., In; Katzung, B.G., Basic and Clinical Pharmacology, 6th Edn., Prentice-Hall International Inc., New York, 1995, 157.
  • 11
    • 77949325643 scopus 로고    scopus 로고
    • US Patent Appl, 09/037 096
    • Pillay, V. and Fassihi, R., US Patent Appl., 09/037 096, 1998.
    • (1998)
    • Pillay, V.1    Fassihi, R.2
  • 12
    • 77949328141 scopus 로고    scopus 로고
    • United States Pharmacopoeia 25, In; United States Pharmacopoeial Convention, Inc., Rockville, MD, 1997, 1475.
    • United States Pharmacopoeia 25, In; United States Pharmacopoeial Convention, Inc., Rockville, MD, 1997, 1475.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.